‘VeinVu 100’ visualizes the vessels on the skin surface by highlighting the vessels as augmented reality by utilizing near-infrared rays and DLP projection technology for patients who are unable to see the vessels during intravenous injections.
This vascular viewer system that can reduce the failure of intravenous injections and increase the success rate is a product everyone can be satisfied with, reducing patient pain, procedural burdens and stress, disposable consumables, and also saving time from failure.
‘VeinVu 100’ is based on the consultation and survey of qualified medical practitioners of intravenous treatment at university hospitals. The research is focused on usability, convenience, and reasonable price. In addition, MAJUTECH developed system modularization and hardware/ software on its own to achieve superior performance, ease of use, and price competitiveness compared to competitors. It will be used in various fields such as general hospitals, cosmetic surgery, public institutions, and national defense.
MAJUTECH Inc. was established in 2015, and it obtained patents for vascular fluoroscopy devices and methods, catheter guide systems, and methods. Starting with the sale of ‘VeinVu 100,’ an intravenous vessel viewer that has been researched with its own technology, the company aims to become the world’s leading manufacturer of intravenous injection with the release of safety catheter and guidance systems. MAJUTECH Inc. will work hard to develop the best-of-breed medical devices that help and satisfy patients, healthcare providers, hospitals, and buyers alike.
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods
Leave a Reply